Understanding the GAP Index for Pulmonary Fibrosis: What It Means for You

TL;DR

• The GAP Index is a simple scoring tool doctors use to predict how pulmonary fibrosis (IPF) may progress.
• It uses your Gender, Age, and two lung function tests (Physiology) to place you in one of three stages.
• A higher stage means a higher risk of disease progression.
• But it's a planning tool, not a definitive verdict.
• Knowing your GAP stage helps you and your doctor make better decisions together.

What Is the GAP Index?

The GAP Index is a scoring system designed specifically for people living with idiopathic pulmonary fibrosis (IPF). Doctors use it to estimate how the disease might progress over the next one to three years.

GAP stands for:

• G — Gender
• A — Age
• P — Physiology (two breathing tests: FVC and DLCO)

It was developed to give doctors and patients a clearer, more standardized way to talk about prognosis and plan care accordingly.

Why Do Doctors Use the GAP Index?

IPF behaves differently from person to person. Some people remain stable for years; others experience faster decline. Without a structured tool, it's hard to predict which path a person will take.

The GAP Index gives your care team a shared language and evidence-based framework. It helps with decisions around treatment intensity, referrals to specialist centers, and whether to discuss lung transplant evaluation early.

Think of it less as a prediction of doom and more as a weather forecast: it tells you what conditions to prepare for, so you can respond wisely.

How Is the GAP Score Calculated?

Your doctor adds up points based on four factors:

Gender

• Female: 0 points
• Male: 1 point

Age

• 60 years or younger: 0 points
• 61–65 years: 1 point
• Older than 65: 2 points

Physiology: FVC (Forced Vital Capacity)

The FVC measures how much air you can blow out after a full breath.

• Greater than 75%: 0 points
• 50–75%: 1 point
• Less than 50%: 2 points

Physiology: DLCO (Diffusing Capacity of the Lungs for Carbon Monoxide)

The DLCO measures how well oxygen passes from your lungs into your bloodstream.

• Greater than 55%: 0 points
• 36–55%: 1 point
• 35% or less: 2 points
• Unable to perform the test: 3 points

Your total score places you into one of three stages.

What Do the GAP Stages Mean?

GAP Stage I (0–3 points)

This is the lowest-risk category. Studies show that roughly 6% of people in Stage I may not survive to one year. This doesn't mean the disease isn't serious, it means the current indicators suggest a slower course, and there is more time to plan.

GAP Stage II (4–5 points)

This is an intermediate stage. The estimated one-year mortality risk rises to around 16–21%. Your doctor may discuss more proactive treatment strategies, closer monitoring, and whether a transplant evaluation is appropriate.

GAP Stage III (6–8 points)

This is the highest-risk stage, with an estimated one-year mortality risk of around 39–62%. If you are in Stage III, your care team will likely want to discuss advanced care planning, transplant eligibility, and specialist support sooner rather than later.

It's important to remember: these are statistical estimates drawn from groups of patients. They are not individual predictions. People in Stage III have lived well beyond estimates; people in Stage I have declined faster. Your score is one piece of a much larger picture.

What the GAP Index Does Not Tell You

The GAP Index is a useful tool, but it has real limits:

• It does not account for acute exacerbations (sudden worsening episodes).
• It does not factor in your response to antifibrotic medications like nintedanib or pirfenidone.
• It does not reflect your quality of life, mental health, or support system- all of which matter enormously.
• It was validated primarily in specific patient populations and may be less accurate in others.

Your GAP stage should always be discussed in the full context of your health history, your symptoms, and your personal goals for care.

Questions to Ask Your Doctor About Your GAP Score

Knowing your score is one thing, understanding what it means for your life is another. These are good questions to bring to your next appointment:

• What is my current GAP stage, and what does that mean for my care plan?
• How often will my lung function tests be repeated to track changes?
• What support services are available to me and my family?

A Note on Living With This Information

Receiving a prognosis, even a statistical one, is hard. It's normal to feel afraid, angry, or overwhelmed. Many people find it helpful to bring a trusted person to appointments, take notes or record conversations with their doctor's permission, and connect with others living with IPF through patient communities.

Organizations like the Pulmonary Fibrosis Foundation offer peer mentorship, support groups, and care center directories. You do not have to interpret any of this alone.

‍

Disclaimer:

This content is informational and not a medical device.

mama health offers information and support and does not replace a doctor.

‍